Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00621452
Brief Title: Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

First Submitted : February 21, 2008
First Submitted that Met QC Criteria : February 21, 2008
First Posted : February 22, 2008 (Estimate)

Last Update Submitted that Met QC Criteria : August 4, 2014
Last Update Posted : August 6, 2014 (Estimate)